Ketamine for Anxiety: What It Is, What Research Shows, and Who It May Help

What ketamine is and how it works

Ketamine is a medicine first approved decades ago as an anesthetic. In low, sub-anesthetic doses given by IV (intravenous) infusion, it acts on the brain’s glutamate system — specifically on receptors called NMDA receptors — to rapidly increase the flexibility of neural circuits involved in mood and fear. That increase in neuroplasticity (the brain’s ability to form new connections) is thought to underlie the rapid symptom changes some patients report.

IV ketamine is not FDA-approved for depression, anxiety, or PTSD; it is used off-label for these conditions. “Off-label” means a clinician prescribes an approved medicine for a use the FDA has not specifically cleared, based on clinical judgment and research. If you are weighing your anxiety treatment options, it helps to know where ketamine fits in the ladder — after, not instead of, first-line care.

What research shows for ketamine in anxiety

Most ketamine research has focused on depression, where studies reported rapid reductions in depressive symptoms within hours to days of a single infusion. Evidence for anxiety specifically is more limited and mixed. In small studies of off-label ketamine for generalized and social anxiety, some patients reported short-term reductions in worry and fear, though effects were not durable for everyone and larger trials were lacking. A consultation at NWCOA reviews your full history before any off-label option is considered. Individual results may vary.

Ketamine vs SPRAVATO®: the FDA distinction

SPRAVATO® (esketamine) is a nasal-spray form of ketamine that is FDA-approved — but for depression, not anxiety. Specifically, it is approved for adults with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder who have acute suicidal thoughts or behavior. It is given in the clinic under a REMS (Risk Evaluation and Mitigation Strategy) program with at least two hours of observation after each dose, and patients must not drive until the next day after a restful sleep.

IV ketamine, by contrast, is not FDA-approved for anxiety. Both act on the glutamate system, but they are different products with different regulatory status. Because SPRAVATO® is approved for depression rather than anxiety, it is generally considered for the depressive component of a person’s condition, not as an anxiety treatment on its own. Learn more on our SPRAVATO® page and our ketamine vs SPRAVATO® comparison.

Ketamine-assisted psychotherapy (KAP)

Ketamine-assisted psychotherapy (KAP) pairs off-label IV ketamine sessions with guided therapy work in the window when ketamine may make thinking more flexible. Therapy before, during, and after the medicine session helps you integrate what comes up. KAP is not a separate medication approval; the ketamine remains off-label for anxiety. Learn more on our ketamine-assisted psychotherapy page.

Who may be a fit for ketamine for anxiety

Off-label ketamine is typically considered only after first-line care — psychotherapy (CBT, DBT, EMDR) and medication management — has been tried and not produced enough relief. It is not a first choice for new anxiety, and it is not for everyone: a full evaluation reviews your history, other conditions, and risks.

Because anxiety often travels with depression, a clinician also checks whether the depression component points to options such as SPRAVATO® or, for depression that has not improved enough on antidepressants, the SAINT® Neuromodulation System — but those treat the depression, not anxiety itself.

What a course of ketamine treatment looks like

A course of IV ketamine is a series of infusions given in our Coral Springs clinic under medical supervision. Each infusion lasts roughly 40–45 minutes, with monitoring before, during, and after. You will not drive yourself home; you will need a ride. There is no home ketamine and no online prescribing at NWCOA. The number of infusions and how often they are given is set by your clinician.

Serving South Florida and patients who travel

We see patients from across Broward County and south Palm Beach County at one clinic in Coral Springs, at 9734 W Sample Rd, Suite B — easily reached from Fort Lauderdale, Pompano Beach, and Parkland via I-95 or the Florida Turnpike to Sample Rd. We also see adults who travel from outside South Florida, including other parts of Florida and other states, for a ketamine series. If you are traveling from outside Broward County, our team can walk you through scheduling during your free consultation.

IV ketamine vs SPRAVATO® vs first-line anxiety care

Frequently asked questions

Cited research

1. Zarate CA Jr, Brutsche NE, Ibrahim L, et al. "Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial." Biol Psychiatry. 2012;71(10):939–946. doi.org/10.1016/j.biopsych.2011.12.006
2. Glue P, Neehoff L, Medlicott NJ, et al. "Safety and efficacy of maintenance ketamine treatment in treatment-resistant depression." J Psychopharmacol. 2020;34(6):655–663. doi.org/10.1177/0269881120914810
3. Taylor VH, Bhat M, Camara-Lara S, et al. "A pilot randomized controlled trial of oral ketamine for treatment-resistant generalized anxiety disorder." J Clin Psychopharmacol. 2020;40(3):263–268. doi.org/10.1097/JCP.0000000000001200
4. U.S. Food and Drug Administration. "FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic." FDA news release, March 5, 2019. fda.gov